- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 7 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain A: E.76, T.77, N.79, N.99, W.227
- Chain F: W.24
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 4 residues within 4Å:- Chain B: D.130, G.160, K.161, N.224
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 7 residues within 4Å:- Chain B: S.111, I.113, N.114, Q.165, N.167, S.169, Y.219
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 9 residues within 4Å:- Chain B: E.76, T.77, N.79, M.80, N.99, W.227
- Chain G: R.23, W.24
- Ligands: NAG-NAG.8
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:R.23, G:W.24
NAG-NAG-BMA.16: 8 residues within 4Å:- Chain C: E.76, T.77, N.79, M.80, N.99, W.227
- Chain H: W.24
- Ligands: NAG.28
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 8 residues within 4Å:- Chain C: S.111, I.113, Q.165, N.167, S.169, H.170, Y.172, Y.219
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.23: 8 residues within 4Å:- Chain B: Q.69
- Chain G: K.32, C.33, F.34, Y.112, N.114, G.119, T.121
No protein-ligand interaction detected (PLIP)- 1 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.21: 13 residues within 4Å:- Chain A: G.197, D.229, C.231, Q.232, F.233, S.234, R.235, S.237
- Chain F: N.106, S.108, V.129, G.132, Y.134
2 PLIP interactions:1 interactions with chain F, 1 interactions with chain A- Hydrophobic interactions: F:Y.134
- Hydrogen bonds: A:Q.232
NAG-NAG-BMA-MAN-MAN-MAN.24: 14 residues within 4Å:- Chain B: G.197, D.229, C.231, Q.232, F.233, S.234, R.235, S.237
- Chain G: N.106, S.108, V.129, G.132, S.133, Y.134
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:C.231, B:Q.232
NAG-NAG-BMA-MAN-MAN-MAN.26: 15 residues within 4Å:- Chain C: M.75, G.197, D.229, C.231, Q.232, F.233, S.234, R.235, S.237
- Chain H: N.106, S.108, V.129, G.132, S.133, Y.134
2 PLIP interactions:1 interactions with chain H, 1 interactions with chain C- Hydrophobic interactions: H:Y.134
- Hydrogen bonds: C:Q.232
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
NAG.28: 4 residues within 4Å:- Chain C: M.80, N.99, E.100
- Ligands: NAG-NAG-BMA.16
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:E.100
NAG.29: 2 residues within 4Å:- Chain F: N.136, H.139
No protein-ligand interaction detected (PLIP)NAG.30: 2 residues within 4Å:- Chain A: C.207
- Chain F: N.131
No protein-ligand interaction detected (PLIP)NAG.31: 4 residues within 4Å:- Chain G: C.101, I.102, S.130, N.131
No protein-ligand interaction detected (PLIP)NAG.32: 1 residues within 4Å:- Chain H: N.136
No protein-ligand interaction detected (PLIP)NAG.33: 3 residues within 4Å:- Chain C: Y.200
- Chain H: N.131, G.132
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.200
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brouwer, P.J.M. et al., Mapping of vaccine-induced humoral responses to the Lassa virus glycoprotein reveals off-target and immunodominant responses. To Be Published
- Release Date
- 2024-09-11
- Peptides
- Glycoprotein G1: ABC
Polyclonal antibody Base-1 heavy chain: D
Polyclonal antibody Base-1 light chain: E
Glycoprotein G2, 2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase fusion protein: FGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
LF
aG
bH
c
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 7 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brouwer, P.J.M. et al., Mapping of vaccine-induced humoral responses to the Lassa virus glycoprotein reveals off-target and immunodominant responses. To Be Published
- Release Date
- 2024-09-11
- Peptides
- Glycoprotein G1: ABC
Polyclonal antibody Base-1 heavy chain: D
Polyclonal antibody Base-1 light chain: E
Glycoprotein G2, 2-dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase fusion protein: FGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
LF
aG
bH
c